Chapter 40. Cardiovascular Risk Factors

  1. Richard I. G. Holt MA, MB BChir, PhD, FRCP, FHEA Professor in Diabetes & Endocrinology4,
  2. Clive S. Cockram MB BS, BSc, MD (Lond), FRCP, FRACP, FHKAM (Med) Emeritus Professor of Medicine5,
  3. Allan Flyvbjerg MD, DMSc Professor of Clinical Endocrinology Chair6 and
  4. Barry J. Goldstein MD, PhD, FACP, FACE Therapeutic Area Head Vice President7
  1. Peter M. Nilsson MD Professor1,
  2. Adie Viljoen MBChB, MMed, FCPath (SA), FRCPath, MBA Consultant2 and
  3. Anthony S. Wierzbicki DM, DPhil, FRCPath, FAHA Consultant3

Published Online: 9 JUL 2010

DOI: 10.1002/9781444324808.ch40

Textbook of Diabetes, Fourth Edition

Textbook of Diabetes, Fourth Edition

How to Cite

Nilsson, P. M., Viljoen, A. and Wierzbicki, A. S. (2010) Cardiovascular Risk Factors, in Textbook of Diabetes, Fourth Edition (eds R. I. G. Holt, C. S. Cockram, A. Flyvbjerg and B. J. Goldstein), Wiley-Blackwell, Oxford, UK. doi: 10.1002/9781444324808.ch40

Editor Information

  1. 4

    Developmental Origins of Health and Disease Division, University of Southampton School of Medicine, Southampton, UK

  2. 5

    Chinese University of Hong Kong, Hong Kong SAR, People's Republic of China

  3. 6

    Department of Endocrinology and Internal Medicine, The Medical Research Laboratories, Aarhus University Hospital – Aarhus University, Aarhus, Denmark

  4. 7

    Clinical Research, Metabolism Merck Research Laboratories Rahway, NJ, USA

Author Information

  1. 1

    Department of Clinical Sciences, Lund University, University Hospital, Malmö, Sweden

  2. 2

    Department of Chemical Pathology, Lister Hospital, Stevenage, UK

  3. 3

    Guy's and St Thomas Hospitals, London, UK

Publication History

  1. Published Online: 9 JUL 2010
  2. Published Print: 9 JUL 2010

ISBN Information

Print ISBN: 9781405191814

Online ISBN: 9781444324808



  • Causes of hypertension in diabetes;
  • Hypertension in the metabolic syndrome;
  • Screening for hypertension in diabetes;
  • Diagnosis of hypertension in diabetes;
  • Investigation of hypertension in diabetes;
  • Management of hypertension in diabetes;
  • angiotensin - converting enzyme (ACE);
  • Angiotensin-converting enzyme inhibitors;
  • Outcome of treating hypertension in diabetes;
  • Special considerations in ethnic groups


This chapter contains sections titled:

  • Introduction

  • Size of the problem

  • Causes of hypertension in diabetes

  • Screening for hypertension in diabetes

  • Diagnosis of hypertension in diabetes

  • Investigation of hypertension in diabetes

  • Management of hypertension in diabetes

  • Special considerations in ethnic groups

  • Outcome of treating hypertension in diabetes

  • Cardiovascular disease risk factors in diabetes

  • Future drug developments and drug targets

  • Conclusions

  • References